NewAmsterdam Pharma Co N.V. (NAMS) › Cost of RevenueNewAmsterdam Pharma Co N.V. (NAMS) — Cost of RevenueAnnual figures by fiscal year, from SEC filings.No annual Cost of Revenue data is available for this company yet.Other metrics: RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share